Literature DB >> 20347660

Candidosis, a new challenge.

Rubén López-Martínez1.   

Abstract

Superficial candidosis is a common fungal infection that could become a gateway to systemic spread. Candida albicans is the most important Candida spp; recently, so-called emergent species, such as C dubliniensis, C famata, and C lipolytica have been isolated. This chapter describes the clinical manifestations and laboratory diagnostic techniques, including direct examination, smears, cultures, and physiologic tests. Topical antifungal drugs available for the treatment of superficial candidosis, including imidazoles, triazoles, allylamines, and nystatin, are also discussed. For granulomatous and invasive forms of candidosis, triazoles, allylamines (terbinafine), echinocandins (caspofungin), and amphotericin B are elective therapeutic choices. It is important to eliminate associated predisposing factors that contribute to infection and, if possible, all samples obtained should be evaluated for cases of resistance. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347660     DOI: 10.1016/j.clindermatol.2009.12.014

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  27 in total

1.  Protease expression by microorganisms and its relevance to crucial physiological/pathological events.

Authors:  André Luis Souza Dos Santos
Journal:  World J Biol Chem       Date:  2011-03-26

2.  Prevalence and distribution profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis responsible for superficial candidiasis in a Chinese university hospital.

Authors:  Xiaobo Feng; Bo Ling; Guimei Yang; Xia Yu; Daming Ren; Zhirong Yao
Journal:  Mycopathologia       Date:  2011-11-19       Impact factor: 2.574

Review 3.  Targeting Candida albicans filamentation for antifungal drug development.

Authors:  Taissa Vila; Jesus A Romo; Christopher G Pierce; Stanton F McHardy; Stephen P Saville; José L Lopez-Ribot
Journal:  Virulence       Date:  2016-06-07       Impact factor: 5.882

Review 4.  Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.

Authors:  Christopher G Pierce; Jose L Lopez-Ribot
Journal:  Expert Opin Drug Discov       Date:  2013-06-06       Impact factor: 6.098

Review 5.  Nanomedicine as an emerging approach against intracellular pathogens.

Authors:  Andrea L Armstead; Bingyun Li
Journal:  Int J Nanomedicine       Date:  2011-12-09

6.  Antifungal and antiovarian cancer properties of α Fe2O3 and α Fe2O3/ZnO nanostructures synthesised by Spirulina platensis.

Authors:  Heba Salah Abbas; Akilandeswari Krishnan; Muddukrishnaiah Kotakonda
Journal:  IET Nanobiotechnol       Date:  2020-12       Impact factor: 1.847

7.  New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges.

Authors:  Anna Vecchiarelli; Eva Pericolini; Elena Gabrielli; Donatella Pietrella
Journal:  Front Microbiol       Date:  2012-08-13       Impact factor: 5.640

8.  Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis.

Authors:  Ali Zarei Mahmoudabadi; Mahin Najafyan; Eskandar Moghimipour; Maryam Alwanian; Zahra Seifi
Journal:  Iran J Microbiol       Date:  2013-03

Review 9.  Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents.

Authors:  Claudia Spampinato; Darío Leonardi
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

10.  Comparative Analysis of Denaturing Gradient Gel Electrophoresis and Temporal Temperature Gradient Gel Electrophoresis Profiles as a Tool for the Differentiation of Candida Species.

Authors:  Parisa Mohammadi; Aida Hamidkhani; Ezat Asgarani
Journal:  Jundishapur J Microbiol       Date:  2015-10-12       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.